Today, ObvioHealth discussed how virtual clinical trials are safer, easier, faster and more efficient for generating the data required to drive innovation. Positive changes are occurring in the clinical-trial industry, as well as in the broader realm of health innovation.
The digital process helps reduce the risk of errors by accelerating enrollment, improving compliance, and reducing dropouts in clinical trials. With this direct approach, ObvioHealth delivers better data. During the trial, new patients can participate from home more easily and safely, and they are more likely to remain engaged.
Patients adhere better to protocols if they are engaged in the process, whether it is reporting events, using digital devices, or taking medication. The result: real-time and complete data is gathered.
At-home clinical trials are proving to be beneficial for sponsors, who are beginning to recognize the advantages. In the modern era, virtual clinical-trial solutions deliver data without a drop-off in data quantity or quality, although some site visits may still be necessary.
The activities typically performed on site (such as dosing and measuring vitals) can be transformed into decentralized study designs with features like continuous monitoring with devices, next-generation ePRO, televisits, etc.
Using a single dashboard, researchers can review all data in real time. By offering virtual clinical-trial solutions, we can prevent the participants from having to perform too many tasks, there’s a higher chance of them completing all study requirements and encourage them to stay completely committed to the study. A higher compliance rate will result in more complete data for sponsors.
Here is how ObvioHealth engages with patients during their journey to encourage conformity:
Online clinical trials are conducted by ObvioHealth using digital recruitment. There are many challenges involved in recruiting participants to on-site clinical trials. Instead of having doctors identify and recommend potential participants, digital recruitment allows them to target potential subjects by scrolling through social media or browsing an internet search engine.
Study staff is available to answer questions via phone or text after recruitment using an electronic informed-consent document. Participants are able to review protocol and consent at their convenience. Participants are enrolled as soon as they sign the eIC, and study materials are sent to their homes.
To find out more about ObvioHealth and the services they offer to companies seeking clinical trials, check out their website here: https://www.obviohealth.com/
ObvioHealth USA, Inc.
ObvioHealth USA, Inc.
3452 Lake Lynda Drive Suite 151